Health Care Financing Administration, HHS.
This final rule eliminates all requirements and references regarding the Cardiac Pacemaker Registry (the Registry) in our regulations. It conforms to the Food and Drug Administration's (FDA) recent final rule that required any physician and any provider of services who requests or receives Medicare payment for the implantation, removal, or replacement of permanent cardiac pacemaker devices and pacemaker leads to submit certain information to the Registry. We used the information to administer Medicare payment for these devices. This rule implements an Act to Repeal An Unnecessary Medical Device Reporting Requirement passed by Congress to eliminate duplicative and unnecessary reporting.
This regulation is effective October 19, 2000.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Shana Olshan, (410) 786-3122.End Further Info End Preamble Start Supplemental Information
On July 23, 1987, we and the FDA jointly issued a final rule establishing the national cardiac pacemaker registry (52 FR 27756), as mandated by the Deficit Reduction Act of 1984 (Public Law 98-369). The final rule for the Registry was codified in 21 CFR part 805. The scope of the regulation provided that the FDA establish a nationwide registry for cardiac pacemakers and pacemaker leads. The FDA used the information submitted to the Registry to track the performance of permanent pacemakers and pacemaker leads and to perform studies and analysis regarding the use of the devices. They transmitted data to us to administer the Medicare program, and to other Federal components to carry out statutory responsibilities.
On October 2, 1996, An act to Repeal An Unnecessary Medical Device Reporting Requirement (Public Law 104-224), which amended title XVIII of the Social Security Act (the Act) (42 U.S.C. 1395), became law. The purpose of the new law was to remove section 1862(h) (42 U.S.C. 1395y(h)) of the Act to eliminate duplicative and unnecessary reporting. The registry was considered duplicative with the requirements of section 519(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360i(e)), which requires that manufacturers track and collect data for certain devices, including permanently implanted pacemakers and pacemaker leads, from the manufacturer, through the distribution chain, to the patient using the device. In accordance with this act, the FDA published a final rule in the Federal Register revoking the Registry on November 24, 1999 (64 FR 66105).
II. Provisions of the Regulation
In response to the FDA revocation of the Registry, we are removing all requirements and references regarding the Registry that appear in our regulations. These appear in 42 CFR Parts 409, 410, 489, and 498. We are revising § 409.1(e) to remove the phrase “* * * and section 1862(h) requires a registry of pacemakers.” We are also removing §§ 409.19 and 410.64, which deal exclusively with requirements for providers and physicians related to the Registry. And we are removing and reserving §§ 489.21(g) and 498.3(b)(10), which contain cross references to §§ 409.19 and 410.64.
III. Waiver of Proposed Rulemaking and Delayed Effective Date
Under section 553(b)(B) of the Administrative Procedure Act (APA), we, for good cause, find that notice and comment procedures are unnecessary because we are not exercising discretion in removing the references to the Registry. And, under section 553(d)(3) of the APA, we, for good cause, waive the 30-day delay in the effective date because Public Law 104-224 was self-implementing.
IV. Regulatory Impact Analysis
We have reviewed this notice under the threshold criteria of Executive Order 13132. We have determined that this final rule will not have substantial direct effects on the states, the relationship between the national government and the States, or the distribution of power and responsibilities among the various levels of government.
Section 202 of the Unfunded Mandates Reform Act of 1995 requires that agencies assess anticipated costs and benefits before issuing any rule that may result in an expenditure by State, local, or tribal governments, in the aggregate, or by the private sector, of $100 million in any one year. This final rule will not have an effect on the governments mentioned, and the private sector costs will not be greater than the $100 million threshold.
We have examined the impacts of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review) and the Regulatory Flexibility Act (RFA) (September 19, 1980 Public Law 96-354). Executive Order 12866 directs agencies to assess all costs and benefits of available regulatory alternatives and, if regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more annually). This rule is not a major rule because costs will not meet this $100 million threshold. The RFA requires agencies to analyze options for regulatory relief of small businesses. For purposes of the RFA, small entities include small businesses, nonprofit organizations and government agencies. Most hospitals and most other providers and suppliers are small entities, either by nonprofit status or by having revenues of $5 million or less annually. Individuals and States are not included in the definition of a small entity.
In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis if a rule may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area and has fewer than 50 beds.
In accordance with the provisions of Executive Order 12866, this final rule was not reviewed by the Office of Management and Budget.Start List of Subjects
List of Subjects
- Administrative practice and procedure
- Health facilities
- Health professions
- Reporting and recordkeeping requirements
For the reasons set forth in the preamble, 42 CFR Chapter IV is amended as follows:End Amendment Part Start Part
PART 409—HOSPITAL INSURANCE BENEFITSEnd Part Start Amendment Part
A. Part 409 is amended as set forth below.End Amendment Part Start Amendment Part
1. The authority citation for part 409 is revised to read as follows:End Amendment Part
2. In § 409.1, paragraph (e) is revised to read as follows:
(e) Section 1862(a) specifies exclusions from coverage.
3. Section 409.19 is removed.End Amendment Part Start Part
PART 410—SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITSEnd Part Start Amendment Part
B. Part 410 is amended as set forth below.End Amendment Part Start Amendment Part
1. The authority citation for part 410 continues to read as follows:End Amendment Part
2. Section 410.64 is removed.End Amendment Part Start Part
PART 489—PROVIDER AGREEMENTS AND SUPPLIER APPROVAL
C. Part 489 is amended as set forth below.
1. The authority citation for part 489 continues to read as follows:
2. In § 489.21, paragraph (g) is removed and reserved.End Amendment Part Start Part
PART 498—APPEALS PROCEDURES FOR DETERMINATIONS THAT AFFECT PARTICIPATION IN THE MEDICARE PROGRAM AND FOR DETERMINATIONS THAT AFFECT THE PARTICIPATION OF ICFS/MR AND CERTAIN NFS IN THE MEDICAID PROGRAMEnd Part Start Amendment Part
D. Part 498 is amended as set forth below.End Amendment Part Start Amendment Part
1. The authority citation for part 498 continues to read as follows:End Amendment Part
2. In § 498.3, paragraph (b)(11) is removed and reserved.End Amendment Part Start Signature
(Catalog of Federal Domestic Assistance Program No. 93.773, Medicare Hospital Insurance; Program No. 93.774, Medicare Supplementary Medical Insurance)
Dated: April 18, 2000.
Nancy-Ann Min DeParle,
Administrator, Health Care Financing Administration.
Dated: May 31, 2000.
Donna E. Shalala,
[FR Doc. 00-26282 Filed 10-18-00; 8:45 am]
BILLING CODE 4120-01-P